Acadian Asset Management
DPLO

Acadian Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Acadian Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,173
Closed -$64K – 1927
2017
Q4 		$64K Buy
+3,173
New +$62.4K ﹤0.01% 1188
2015
Q4 		– Sell
-122
Closed -$4K – 1560
2015
Q3 		$4K Buy
+122
New +$5.22K ﹤0.01% 1236

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Acadian Asset Management's DPLO Position: Q1 2018 in Review

Acadian Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2018, closing a stake of 3,173 shares — an estimated $64K sold.

Acadian Asset Management first reported a position in DPLO in Q3 2015 and held it in 2 quarters. The position peaked at $64K in Q4 2017. 201 funds tracked by Wall St. Rank hold DPLO as of Q1 2018.

  • Acadian Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2018 after selling out during the quarter.
  • Acadian Asset Management sold 3,173 DIPLOMAT PHARMACY, INC. shares in Q1 2018, an estimated $64K.
  • Acadian Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 2 quarters.
  • Acadian Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $64K in Q4 2017.
  • 201 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2018.

Based on Acadian Asset Management's 13F filing for Q1 2018, filed 12 Apr 2018.